NurExone Biologic (NRX.V) raised approximately C$627,795.26 through a non-brokered private placement of around 1 million units priced at C$0.62 each, it said Tuesday.
Each unit is made up of a share and a warrant entitling the holder to buy a share at a price of C$0.78 for a period of three years from the closing date, subject to acceleration, said the company.
Proceeds are planned to be used for general working capital purposes and closing of the offering is subject to regulatory approvals, added NurExone.